Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novanta (NOVT) Research & Development (2016 - 2025)

Novanta (NOVT) has disclosed Research & Development for 16 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 9.56% year-over-year to $22.9 million, compared with a TTM value of $95.5 million through Dec 2025, changed 0.03%, and an annual FY2025 reading of $95.5 million, changed 0.03% over the prior year.
  • Research & Development was $22.9 million for Q4 2025 at Novanta, down from $24.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $25.3 million in Q2 2025 and bottomed at $17.0 million in Q3 2021.
  • Average Research & Development over 5 years is $22.0 million, with a median of $22.8 million recorded in 2023.
  • The sharpest move saw Research & Development rose 27.33% in 2022, then dropped 9.56% in 2025.
  • Year by year, Research & Development stood at $19.4 million in 2021, then rose by 12.8% to $21.9 million in 2022, then rose by 7.07% to $23.5 million in 2023, then grew by 7.82% to $25.3 million in 2024, then decreased by 9.56% to $22.9 million in 2025.
  • Business Quant data shows Research & Development for NOVT at $22.9 million in Q4 2025, $24.1 million in Q3 2025, and $25.3 million in Q2 2025.